Click for best price
Cancer Drug Therapy Market Size, Share 2022
Market Analysis and Insights: Global Cancer Drug Therapy Market
The global Cancer Drug Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Drug Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Drug Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Drug Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Drug Therapy market.
Global Cancer Drug Therapy Scope and Market Size
Cancer Drug Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cancer Drug Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Cancer Drug Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Targeted Therapy
Chemotherapy
Immunotherapy
Segment by Application
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Cancer Drug Therapy product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Cancer Drug Therapy, with price, sales, revenue, and global market share of Cancer Drug Therapy from 2019 to 2022.
Chapter 3, the Cancer Drug Therapy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Drug Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Cancer Drug Therapy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Drug Therapy.
Chapter 13, 14, and 15, to describe Cancer Drug Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Cancer Drug Therapy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Cancer Drug Therapy Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Cancer Drug Therapy Product Introduction
1.2 Global Cancer Drug Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cancer Drug Therapy Sales in US$ Million for the Year 2017-2028
1.2.2 Global Cancer Drug Therapy Sales in Volume for the Year 2017-2028
1.3 United States Cancer Drug Therapy Outlook 2017 VS 2022 VS 2028
1.3.1 United States Cancer Drug Therapy Sales in US$ Million for the Year 2017-2028
1.3.2 United States Cancer Drug Therapy Sales in Volume for the Year 2017-2028
1.4 Cancer Drug Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Cancer Drug Therapy in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Cancer Drug Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Cancer Drug Therapy Market Dynamics
1.5.1 Cancer Drug Therapy Industry Trends
1.5.2 Cancer Drug Therapy Market Drivers
1.5.3 Cancer Drug Therapy Market Challenges
1.5.4 Cancer Drug Therapy Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Cancer Drug Therapy Market Segment by Type
2.1.1 Targeted Therapy
2.1.2 Chemotherapy
2.1.3 Immunotherapy
2.2 Global Cancer Drug Therapy Market Size by Type
2.2.1 Global Cancer Drug Therapy Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Cancer Drug Therapy Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Cancer Drug Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Cancer Drug Therapy Market Size by Type
2.3.1 United States Cancer Drug Therapy Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Cancer Drug Therapy Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Cancer Drug Therapy Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Cancer Drug Therapy Market Segment by Application
3.1.1 Angiogenesis Inhibitors
3.1.2 mTOR Inhibitors
3.1.3 Monoclonal Antibodies
3.1.4 Cytokine Immunotherapy (IL-2)
3.2 Global Cancer Drug Therapy Market Size by Application
3.2.1 Global Cancer Drug Therapy Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Cancer Drug Therapy Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Cancer Drug Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Cancer Drug Therapy Market Size by Application
3.3.1 United States Cancer Drug Therapy Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Cancer Drug Therapy Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Cancer Drug Therapy Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Cancer Drug Therapy Competitor Landscape by Company
4.1 Global Cancer Drug Therapy Market Size by Company
4.1.1 Top Global Cancer Drug Therapy Manufacturers Ranked by Revenue (2021)
4.1.2 Global Cancer Drug Therapy Revenue by Manufacturer (2017-2022)
4.1.3 Global Cancer Drug Therapy Sales by Manufacturer (2017-2022)
4.1.4 Global Cancer Drug Therapy Price by Manufacturer (2017-2022)
4.2 Global Cancer Drug Therapy Concentration Ratio (CR)
4.2.1 Cancer Drug Therapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cancer Drug Therapy in 2021
4.2.3 Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cancer Drug Therapy Manufacturing Base Distribution, Product Type
4.3.1 Global Cancer Drug Therapy Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Cancer Drug Therapy Product Type
4.3.3 Date of International Manufacturers Enter into Cancer Drug Therapy Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Cancer Drug Therapy Market Size by Company
4.5.1 Top Cancer Drug Therapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cancer Drug Therapy Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Cancer Drug Therapy Sales by Players (2020, 2021 & 2022)
5 Global Cancer Drug Therapy Market Size by Region
5.1 Global Cancer Drug Therapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cancer Drug Therapy Market Size in Volume by Region (2017-2028)
5.2.1 Global Cancer Drug Therapy Sales in Volume by Region: 2017-2022
5.2.2 Global Cancer Drug Therapy Sales in Volume Forecast by Region (2023-2028)
5.3 Global Cancer Drug Therapy Market Size in Value by Region (2017-2028)
5.3.1 Global Cancer Drug Therapy Sales in Value by Region: 2017-2022
5.3.2 Global Cancer Drug Therapy Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.1.2 North America Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cancer Drug Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.3.2 Europe Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cancer Drug Therapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cancer Drug Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Amgen / Allergan
7.1.1 Amgen / Allergan Corporation Information
7.1.2 Amgen / Allergan Description and Business Overview
7.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
7.1.5 Amgen / Allergan Recent Development
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Corporation Information
7.2.2 Argos Therapeutics Description and Business Overview
7.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Argos Therapeutics Cancer Drug Therapy Products Offered
7.2.5 Argos Therapeutics Recent Development
7.3 AstraZeneca
7.3.1 AstraZeneca Corporation Information
7.3.2 AstraZeneca Description and Business Overview
7.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.3.4 AstraZeneca Cancer Drug Therapy Products Offered
7.3.5 AstraZeneca Recent Development
7.4 Aveo Pharmaceuticals
7.4.1 Aveo Pharmaceuticals Corporation Information
7.4.2 Aveo Pharmaceuticals Description and Business Overview
7.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Products Offered
7.4.5 Aveo Pharmaceuticals Recent Development
7.5 Bayer
7.5.1 Bayer Corporation Information
7.5.2 Bayer Description and Business Overview
7.5.3 Bayer Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bayer Cancer Drug Therapy Products Offered
7.5.5 Bayer Recent Development
7.6 Exelixis
7.6.1 Exelixis Corporation Information
7.6.2 Exelixis Description and Business Overview
7.6.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Exelixis Cancer Drug Therapy Products Offered
7.6.5 Exelixis Recent Development
7.7 Incyte
7.7.1 Incyte Corporation Information
7.7.2 Incyte Description and Business Overview
7.7.3 Incyte Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Incyte Cancer Drug Therapy Products Offered
7.7.5 Incyte Recent Development
7.8 Merck
7.8.1 Merck Corporation Information
7.8.2 Merck Description and Business Overview
7.8.3 Merck Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Merck Cancer Drug Therapy Products Offered
7.8.5 Merck Recent Development
7.9 Roche
7.9.1 Roche Corporation Information
7.9.2 Roche Description and Business Overview
7.9.3 Roche Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Roche Cancer Drug Therapy Products Offered
7.9.5 Roche Recent Development
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Corporation Information
7.10.2 Bristol-Myers Squibb Description and Business Overview
7.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Bristol-Myers Squibb Cancer Drug Therapy Products Offered
7.10.5 Bristol-Myers Squibb Recent Development
7.11 Eisai
7.11.1 Eisai Corporation Information
7.11.2 Eisai Description and Business Overview
7.11.3 Eisai Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Eisai Cancer Drug Therapy Products Offered
7.11.5 Eisai Recent Development
7.12 Exelixis
7.12.1 Exelixis Corporation Information
7.12.2 Exelixis Description and Business Overview
7.12.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Exelixis Products Offered
7.12.5 Exelixis Recent Development
7.13 Genentech (Roche)
7.13.1 Genentech (Roche) Corporation Information
7.13.2 Genentech (Roche) Description and Business Overview
7.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Genentech (Roche) Products Offered
7.13.5 Genentech (Roche) Recent Development
7.14 Novartis
7.14.1 Novartis Corporation Information
7.14.2 Novartis Description and Business Overview
7.14.3 Novartis Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Novartis Products Offered
7.14.5 Novartis Recent Development
7.15 Pfizer
7.15.1 Pfizer Corporation Information
7.15.2 Pfizer Description and Business Overview
7.15.3 Pfizer Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Pfizer Products Offered
7.15.5 Pfizer Recent Development
7.16 Prometheus Labs
7.16.1 Prometheus Labs Corporation Information
7.16.2 Prometheus Labs Description and Business Overview
7.16.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Prometheus Labs Products Offered
7.16.5 Prometheus Labs Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Cancer Drug Therapy Industry Chain Analysis
8.2 Cancer Drug Therapy Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Cancer Drug Therapy Distributors
8.3 Cancer Drug Therapy Production Mode & Process
8.4 Cancer Drug Therapy Sales and Marketing
8.4.1 Cancer Drug Therapy Sales Channels
8.4.2 Cancer Drug Therapy Distributors
8.5 Cancer Drug Therapy Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Drug Therapy CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Cancer Drug Therapy Market Trends
Table 3. Cancer Drug Therapy Market Drivers
Table 4. Cancer Drug Therapy Market Challenges
Table 5. Cancer Drug Therapy Market Restraints
Table 6. Global Cancer Drug Therapy Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Cancer Drug Therapy Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Cancer Drug Therapy Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Cancer Drug Therapy Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Cancer Drug Therapy Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Cancer Drug Therapy Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Cancer Drug Therapy Revenue Share by Manufacturer, 2017-2022
Table 13. Global Cancer Drug Therapy Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Cancer Drug Therapy Sales Share by Manufacturer, 2017-2022
Table 15. Global Cancer Drug Therapy Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Cancer Drug Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2021)
Table 18. Top Players of Cancer Drug Therapy in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Cancer Drug Therapy Product Type
Table 20. Date of International Manufacturers Enter into Cancer Drug Therapy Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Cancer Drug Therapy Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Cancer Drug Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Cancer Drug Therapy Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Cancer Drug Therapy Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Cancer Drug Therapy Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Cancer Drug Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Cancer Drug Therapy Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Cancer Drug Therapy Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Cancer Drug Therapy Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Cancer Drug Therapy Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Cancer Drug Therapy Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Cancer Drug Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Cancer Drug Therapy Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Cancer Drug Therapy Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Cancer Drug Therapy Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Cancer Drug Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Cancer Drug Therapy Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Cancer Drug Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Cancer Drug Therapy Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Cancer Drug Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Amgen / Allergan Corporation Information
Table 43. Amgen / Allergan Description and Business Overview
Table 44. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Amgen / Allergan Cancer Drug Therapy Product
Table 46. Amgen / Allergan Recent Development
Table 47. Argos Therapeutics Corporation Information
Table 48. Argos Therapeutics Description and Business Overview
Table 49. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Argos Therapeutics Product
Table 51. Argos Therapeutics Recent Development
Table 52. AstraZeneca Corporation Information
Table 53. AstraZeneca Description and Business Overview
Table 54. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. AstraZeneca Product
Table 56. AstraZeneca Recent Development
Table 57. Aveo Pharmaceuticals Corporation Information
Table 58. Aveo Pharmaceuticals Description and Business Overview
Table 59. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Aveo Pharmaceuticals Product
Table 61. Aveo Pharmaceuticals Recent Development
Table 62. Bayer Corporation Information
Table 63. Bayer Description and Business Overview
Table 64. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Bayer Product
Table 66. Bayer Recent Development
Table 67. Exelixis Corporation Information
Table 68. Exelixis Description and Business Overview
Table 69. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Exelixis Product
Table 71. Exelixis Recent Development
Table 72. Incyte Corporation Information
Table 73. Incyte Description and Business Overview
Table 74. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Incyte Product
Table 76. Incyte Recent Development
Table 77. Merck Corporation Information
Table 78. Merck Description and Business Overview
Table 79. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Merck Product
Table 81. Merck Recent Development
Table 82. Roche Corporation Information
Table 83. Roche Description and Business Overview
Table 84. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Roche Product
Table 86. Roche Recent Development
Table 87. Bristol-Myers Squibb Corporation Information
Table 88. Bristol-Myers Squibb Description and Business Overview
Table 89. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Bristol-Myers Squibb Product
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Eisai Corporation Information
Table 93. Eisai Description and Business Overview
Table 94. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Eisai Product
Table 96. Eisai Recent Development
Table 97. Exelixis Corporation Information
Table 98. Exelixis Description and Business Overview
Table 99. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Exelixis Product
Table 101. Exelixis Recent Development
Table 102. Genentech (Roche) Corporation Information
Table 103. Genentech (Roche) Description and Business Overview
Table 104. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Genentech (Roche) Product
Table 106. Genentech (Roche) Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Business Overview
Table 109. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Pfizer Corporation Information
Table 113. Pfizer Description and Business Overview
Table 114. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Pfizer Product
Table 116. Pfizer Recent Development
Table 117. Prometheus Labs Corporation Information
Table 118. Prometheus Labs Description and Business Overview
Table 119. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Prometheus Labs Product
Table 121. Prometheus Labs Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Cancer Drug Therapy Customers List
Table 125. Cancer Drug Therapy Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Drug Therapy Product Picture
Figure 2. Global Cancer Drug Therapy Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Cancer Drug Therapy Market Size 2017-2028 (US$ Million)
Figure 4. Global Cancer Drug Therapy Sales 2017-2028 (K Units)
Figure 5. United States Cancer Drug Therapy Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Cancer Drug Therapy Market Size 2017-2028 (US$ Million)
Figure 7. United States Cancer Drug Therapy Sales 2017-2028 (K Units)
Figure 8. United States Cancer Drug Therapy Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Cancer Drug Therapy Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Cancer Drug Therapy Report Years Considered
Figure 11. Product Picture of Targeted Therapy
Figure 12. Product Picture of Chemotherapy
Figure 13. Product Picture of Immunotherapy
Figure 14. Global Cancer Drug Therapy Market Share by Type in 2022 & 2028
Figure 15. Global Cancer Drug Therapy Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Cancer Drug Therapy Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Cancer Drug Therapy Sales by Type (2017-2028) & (K Units)
Figure 18. Global Cancer Drug Therapy Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Cancer Drug Therapy Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Cancer Drug Therapy Market Share by Type in 2022 & 2028
Figure 21. United States Cancer Drug Therapy Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Cancer Drug Therapy Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Cancer Drug Therapy Sales by Type (2017-2028) & (K Units)
Figure 24. United States Cancer Drug Therapy Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Cancer Drug Therapy Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Angiogenesis Inhibitors
Figure 27. Product Picture of mTOR Inhibitors
Figure 28. Product Picture of Monoclonal Antibodies
Figure 29. Product Picture of Cytokine Immunotherapy (IL-2)
Figure 30. Global Cancer Drug Therapy Market Share by Application in 2022 & 2028
Figure 31. Global Cancer Drug Therapy Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Cancer Drug Therapy Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Cancer Drug Therapy Sales by Application (2017-2028) & (K Units)
Figure 34. Global Cancer Drug Therapy Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Cancer Drug Therapy Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Cancer Drug Therapy Market Share by Application in 2022 & 2028
Figure 37. United States Cancer Drug Therapy Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Cancer Drug Therapy Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Cancer Drug Therapy Sales by Application (2017-2028) & (K Units)
Figure 40. United States Cancer Drug Therapy Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Cancer Drug Therapy Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Cancer Drug Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Cancer Drug Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Cancer Drug Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Cancer Drug Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Cancer Drug Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Cancer Drug Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Cancer Drug Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Cancer Drug Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Cancer Drug Therapy Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Cancer Drug Therapy Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. UAE Cancer Drug Therapy Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Cancer Drug Therapy Value Chain
Figure 76. Cancer Drug Therapy Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
